CFR ditches Adcock bid

CFR ditches Adcock bid


Chilean drugmaker CFR Pharmaceuticals on Friday formally abandoned a bid for South African firm Adcock Ingram. The news followed a fraught negotiation process since CFR first proposed the acquisition in July. The acquisition of 34.5% of Adcock by a consortium led by the Bidvest Group, a South African conglomerate, at ZAR70 ($6.33) per share in January was what finally ended the deal. CFR would not have the 75% majority needed for its bid to go through, the Chilean said on Friday. “As a disciplin

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial